Oracle said talks for an equity deal to support its Michigan data center project remain on schedule and do not include Blue ...

Oracle faces downside risk with $100B debt, tripled leases, halted buybacks, equity issuance, and elevated valuation versus historical norms. Read why ORCL stock is a hold.

Oracle (ORCL) is rated 'Buy' due to a major valuation dislocation versus its $523B RPO backlog, despite recent CapEx-driven ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

AI investors are scrutinizing a once-obscure metric related to future sales.